The selective effect of TLK2 inhibition against TLK2-high breast cancer cells as compared with benign breast epithelial cells suggests a possible more selective cellular effect of TLK2 inhibitors as compared with the inhibitors of other cell cycle kinases that do not show cancer cell specificity. Here, TLK2 is linked to breast carcinoma.